Sanford C. Bernstein set a €30.00 ($34.88) target price on Evonik Industries (FRA:EVK) in a report published on Monday, January 13th, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
EVK has been the subject of a number of other research reports. HSBC set a €25.00 ($29.07) price target on Evonik Industries and gave the stock a neutral rating in a research note on Wednesday, September 18th. Credit Suisse Group set a €25.00 ($29.07) price objective on Evonik Industries and gave the company a neutral rating in a research report on Tuesday, November 5th. Kepler Capital Markets set a €23.00 ($26.74) price objective on Evonik Industries and gave the company a sell rating in a research report on Tuesday, November 12th. Bank of America set a €24.00 ($27.91) price objective on Evonik Industries and gave the company a sell rating in a research report on Friday, September 20th. Finally, Berenberg Bank set a €30.00 ($34.88) price objective on Evonik Industries and gave the company a buy rating in a research report on Tuesday, November 12th. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and eleven have given a buy rating to the company. The company presently has an average rating of Hold and a consensus price target of €28.65 ($33.32).
Shares of FRA EVK traded up €0.74 ($0.86) during midday trading on Monday, hitting €26.11 ($30.36). 1,864,179 shares of the stock traded hands. Evonik Industries has a one year low of €26.78 ($31.14) and a one year high of €32.97 ($38.34). The firm has a 50-day moving average of €26.29 and a two-hundred day moving average of €24.72.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Read More: What are the benefits of investing in REITs?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.